Breast Cancer Survivors' Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence

被引:12
|
作者
Ibrar, Maryam [1 ]
Peddie, Nicola [1 ]
Agnew, Sommer [1 ]
Diserholt, Amanda [2 ]
Fleming, Leanne [1 ]
机构
[1] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Scotland
[2] Canterbury Christ Church Univ, Sch Psychol & Life Sci, Canterbury, England
来源
FRONTIERS IN PSYCHOLOGY | 2022年 / 13卷
关键词
breast cancer; hormone therapy; lived experience; side effects; adherence; COGNITIVE-BEHAVIOR THERAPY; ENDOCRINE THERAPY; INSOMNIA; WOMEN; PERSISTENCE; DEPRESSION; RECURRENCE; TAMOXIFEN; SYMPTOMS; EFFICACY;
D O I
10.3389/fpsyg.2022.861198
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
ObjectivesSide effects from Hormone Therapy (HT) impact medication adherence in breast cancer survivors. Understanding the most distressing HT side effects and their impacts may inform the development and implementation of interventions to alleviate these side effects and maximise HT adherence. This study aimed to explore the lived experience of adjuvant HT and understand the impact of HT side effects on adherence in a sample of breast cancer survivors. MethodsTwenty-five female breast cancer survivors who were currently taking adjuvant HT participated in the study. One-to-one, online, semi-structured interviews were conducted to explore (i) specific side effects from HT and (ii) the impact of these side effects on HT adherence. Data were analysed using Thematic Analysis. ResultsThe most commonly reported side effects were sleep disturbance, hot flashes, anxiety, and joint pain. Data exploring the impacts of these side effects on HT adherence were thematically synthesised into four analytical themes: "A bitter pill to swallow," "Seeking relief," "Taking control," and "The only way out is through." These themes encompass 14 sub-themes that encapsulate participants' daily struggle with HT side effects and the coping strategies developed to manage these. ConclusionAdverse side effects from HT, such as sleep disturbance, hot flashes, pain and anxiety, impair quality of life and increase the likelihood of participants' becoming non-adherent to HT medication. In order to maximise HT adherence and reduce breast cancer mortality, HT side effects should be closely monitored to identify individuals who would benefit from targetted intervention strategies aimed at alleviating these side effects.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis
    Peddie, Nicola
    Agnew, Sommer
    Crawford, Megan
    Dixon, Diane
    MacPherson, Iain
    Fleming, Leanne
    BREAST, 2021, 58 : 147 - 159
  • [2] The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review
    Fleming, Leanne
    Agnew, Sommer
    Peddie, Nicola
    Crawford, Megan
    Dixon, Diane
    MacPherson, Iain
    BREAST, 2022, 64 : 63 - 84
  • [3] Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer
    Neuner, Joan M.
    Fergestrom, Nicole
    Pezzin, Liliana E.
    Laud, Purushottam W.
    Ruddy, Kathryn J.
    Winn, Aaron N.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (01) : 223 - 233
  • [4] Patients' Experience of Medication Brand Changes during Hormone Therapy for Breast Cancer-An Interpretative Phenomenological Analysis
    Eraso, Yolanda
    Moon, Zoe
    Steinberga, Ieva
    HEALTHCARE, 2022, 10 (12)
  • [5] How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support
    Berkowitz, Maurice J.
    Thompson, Carlie K.
    Zibecchi, Laura T.
    Lee, Minna K.
    Streja, Elani
    Berkowitz, Jacob S.
    Wenziger, Cachet M.
    Baker, Jennifer L.
    DiNome, Maggie L.
    Attai, Deanna J.
    JOURNAL OF CANCER SURVIVORSHIP, 2021, 15 (01) : 29 - 39
  • [6] Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research
    Van Liew, Julia R.
    Christensen, Alan J.
    de Moor, Janet S.
    JOURNAL OF CANCER SURVIVORSHIP, 2014, 8 (03) : 521 - 531
  • [7] Assessing Adherence to Adjuvant Hormone Therapy in Breast Cancer Patients in Routine Clinical Practice
    Camejo, Natalia
    Castillo, Cecilia
    Tambasco, Clara
    Strazzarino, Noelia
    Requena, Nicolas
    Peraza, Silvina
    Boronat, Anna
    Herrera, Guadalupe
    Esperon, Patricia
    Cuello, Mauricio
    Krygier, Gabriel
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (04) : 300 - 308
  • [8] The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation
    Gomaa, Sameh
    Lopez, Anamaria
    Slamon, Rachel
    Smith, Rita
    Lapitan, Emmanuel
    Nightingale, Ginah
    Miller, Suzanne M.
    Wen, Kuang-Yi
    SUPPORTIVE CARE IN CANCER, 2023, 31 (12)
  • [9] Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence
    Pourcelot, Charlotte
    Orillard, Emeline
    Nallet, Gilles
    Dirand, Camille
    Billion-Rey, Francois
    Barbier, Garance
    Chouk, Sarah
    Limat, Samuel
    Montcuquet, Philippe
    Henriques, Julie
    Paget-Bailly, Sophie
    Anota, Amelie
    Chaigneau, Loic
    Nerich, Virginie
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (01) : 153 - 162
  • [10] Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review
    Moon, Zoe
    Moss-Morris, Rona
    Hunter, Myra S.
    Carlisle, Sophie
    Hughes, Lyndsay D.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 305 - 322